Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 29, 2026

Sep. 29, 2026

Americase International Symposium: Live Battery Failure Testing With Expert Sessions on Transport, Storage & Recycling

Indeterminate EIN Presswire

Sep. 29, 2026

TherapyDial help Clinicians into Thriving Solo Practitioners in Under 90 Days

Indeterminate EIN Presswire

Sep. 29, 2026

LAMP Draws 204 Applicants Across 35 Open Roles as of September 28, as Liberty County Site Builds Operational Workforce

Indeterminate EIN Presswire

Sep. 29, 2026

Keep Safe Care Acquires Four Caregiver-Recruitment Websites for Planned 2027 Platform Launch

Indeterminate EIN Presswire

Sep. 29, 2026

Houston Eye Clinic Texas State Optical Champions Provides Comprehensive Medical Eye Exams for Complex Eye Conditions

Indeterminate EIN Presswire

Sep. 29, 2026

EMERGING TECH: Pelara Begins Collaboration with San Antonio Zoo to Explore Focused Ultrasound in Zoological Medicine

Indeterminate EIN Presswire

Sep. 29, 2026

Nobis Names Cynthia A. Gray as Chief Financial Officer

Indeterminate EIN Presswire

Sep. 29, 2026

BlueCloudX Donates $25 Million to MENASA Group to Advance Health Equity, Clinical Research and Life Sciences Education

Indeterminate EIN Presswire

Sep. 29, 2026

Solaris Endovascular Expands Leadership Team to Support Global Growth and Commercialization

Indeterminate EIN Presswire

Sep. 29, 2026

Plutus Health Redefines RCM Around Financial Outcomes, Payer Intelligence, and Agentic AI

Indeterminate EIN Presswire

Sep. 29, 2026

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Indeterminate GlobeNewswire

Sep. 29, 2026

DBV Technologies annonce le dépôt de sa demande de licence biologique (BLA) auprès de la Food and Drug Administration des Etats-Unis pour le patch VIASKIN® Peanut destiné aux enfants âgés de 4 à 7 ans.

Indeterminate GlobeNewswire

Sep. 29, 2026

Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

Indeterminate GlobeNewswire

Sep. 29, 2026

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Sep. 29, 2026

HL7 Launches Break the Code to Build the Next Generation of Healthcare Interoperability Talent

Indeterminate GlobeNewswire

Sep. 29, 2026

CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pyxis Oncology Announces Proposed Public Offering

Indeterminate GlobeNewswire

Sep. 29, 2026

Vireo Growth Inc. Announces Put/Call Agreement in Connection with Loan Acquisition

Indeterminate GlobeNewswire

Sep. 29, 2026

Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 29, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire